03.02 Drugs for Peptic Ulcer Disease Flashcards
Distal to the junction between antrum and acid secretory mucosa High risk of malignancy H. pylori, NSAID-induced Gastric acid output normal or decreased Burning or gnawing discomfort Precipitated by food
Gastric ulcer
First portion of the duodenum (within 3 cm of pylorus)
Rare risk of malignancy
H. pylori, NSAIDS
High gastric acid secretion, low bicarbonate secretion
Burning or gnawing, awakens at night
90 minutes to 3 hours after a meal, relieved by antacids or food
Duodenal ulcer
Burning pain on epigastric region, often accompanied by a feeling of post-prandial fullness
Dyspepsia
Protective factors of GI mucosa
Bicarbonate
Gastric mucosa
Prostaglandins
Nitric oxide
Damaging factors of GI mucosa
Stress and trauma NSAIDS H. pylori Caffeine Acids Skipping meals Smoking, alcohol
Rebound acidity, diarrhea, constipation, metabolic alkalosis, abdominal distension, gas flatulence
Antacids
Dizziness, inhibition of CYP450, hormonal imbalances, Vit B12 supplementation
H2 receptor antagonists
CYP450 inhibition, rebound acidity, Vit B12 supplementation
PPI
Constipation, flatulence, dry mouth
Sulcralfate
Blackening of tongue and stool
Bismuth chelate
Empiric trial acid suppresion for ___ is the recommended line of therapy
4-8 weeks
If initial acid suppression fails after ___, it is reasonable to step up therapy
2-4 weeks
Most sensitive and specific approach for examining the upper GI tract
Direct visualization of the mucosa
Test for malignancy
Endoscopy
Other diagnostic procedures for peptic ulcer diseases
Barium studies
H. pylori detection (urease test)
Two types of antacids
Bicarbonates
Hydroxides
Acid neutralizer only
Rapidly neutralizing HCl and reducing pepsin activity
Stimulate mucosal prostaglandin production
Weak bases that react with H+ to form a salt and water
Fast onset, short duration
Antacids
Symptomatic relief of acid peptic disorders
Reduce the phosphorus levels among patients with renal insufficiency/failure
Ca2+ supplement for patients with osteoporosis or hypocalcemia
Antacids
Adverse effects of antacids
Metabolic alkalosis
Rebound acidity
Increased acid secretion due to negative feedback
Milk-alkali syndrome
Flatulence, abdominal distention, bloating or belching
CI in patients with cardiac or renal problems
Sodium bicarbonate
Increase acid secretion due to negative feedback
Calcium carbonate
Osmotic diarrhea
Hypermagnesemia
Flatulence
Mg(OH)2
Constipation
Usually combined with Mg(OH)2
Hypophosphatemia
Flatulence
Al(OH)3
Cimetidine, ranitidine, nizatidine, famotidine
H2 receptor antagonist
Technically an antihistamine
Block H2 receptors of the parietal cells via competitive inhibition
Reduces the direct-stimulatory effect of gastrin and acetylcholine
Suppress basal gastric acid secretion
Longer effect than antacids
H2 receptor antagonist